Goldwind Science & Technology Co Ltd
SWB:CXGH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Goldwind Science & Technology Co Ltd
SWB:CXGH
|
CN |
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
Lantronix Inc
NASDAQ:LTRX
|
US |
|
K
|
Kongsberg Gruppen ASA
OSE:KOG
|
NO |
|
V
|
Versant Media Group Inc
NASDAQ:VSNT
|
US |
|
N4 Pharma PLC
LSE:THAT
|
UK |
|
CTS Corp
NYSE:CTS
|
US |
|
Nomura Research Institute Ltd
OTC:NURAF
|
JP |
|
P
|
Perusahaan Perkebunan London Sumatra Indonesia Tbk PT
SWB:PS9A
|
ID |
|
Hera SpA
MIL:HER
|
IT |
|
Indocement Tunggal Prakarsa Tbk PT
IDX:INTP
|
ID |
|
Desert Control AS
F:8KT
|
NO |
Wall St Price Targets
CXGH Price Targets Summary
Goldwind Science & Technology Co Ltd
According to Wall Street analysts, the average 1-year price target for CXGH is 1.7284 EUR with a low forecast of 1.0883 EUR and a high forecast of 2.2833 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CXGH's stock price target?
Price Target
1.7284
EUR
According to Wall Street analysts, the average 1-year price target for CXGH is 1.7284 EUR with a low forecast of 1.0883 EUR and a high forecast of 2.2833 EUR.
What is the Revenue forecast for Goldwind Science & Technology Co Ltd?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is 15%.
What is the Operating Income forecast for Goldwind Science & Technology Co Ltd?
Projected CAGR
34%
Over the last 14 years, the compound annual growth rate for Operating Income has been 19%. The projected CAGR for the next 2 years is 34%.
What is the Net Income forecast for Goldwind Science & Technology Co Ltd?
Projected CAGR
35%
Over the last 14 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 3 years is 35%.
